Activities of Some Cannabinoids as Predicted by Molecular Docking Computation and Confirmed by Cell Calcium Assay
preprint
OA: closed
CC-BY-4.0
AI-generated summary
Molecular docking predicted that cannabinol (CBN) and cannabichromene (CBC) would be bioactive on TRPV1 and TRPC5 receptors, which cell calcium assays confirmed for CBN and CBC but not cannabicyclol (CBL).
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Many cannabinoids are derived from Cannabis and exhibit a diverse range of pharmacological properties. Predictions of bioactivities of these compounds were conducted by molecular docking computation on two transient receptor potential (TRP) receptors (TRPV1 and TRPC5) found on human glioma (U-87 MG) cells. These predictions were experimentally confirmed by monitoring changes in intracellular calcium concentration in U-87 MG cells treated with cannabinol (CBN), cannabichromene (CBC), and cannabicyclol (CBL), as measured using a fluorescence microplate reader. The results indicate that CBN and CBC are bioactive, whereas CBL exhibits minimal activity. These findings are consistent with predictions obtained from molecular docking computation based on AutoDock Vina.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00
- unpaywall
- last seen: 2026-05-26T02:00:01.498150+00:00
License: CC-BY-4.0